Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Expands Scientific Advisory Board

Published: Thursday, November 08, 2012
Last Updated: Thursday, November 08, 2012
Bookmark and Share
Dr. Klaus Lindpaintner to lead strategic development of innovative analytical technologies.

Thermo Fisher Scientific Inc. announced that Klaus Lindpaintner, MD, MPH, and Edison T. Liu, MD, have joined its Scientific Advisory Board. The board was created in 2010 to formalize the two-way exchange of technological information between the company and representatives from some of the world’s premier centers of health, science and education.

Dr. Lindpaintner became an internal member of the Scientific Advisory Board after recently joining Thermo Fisher in the newly created role of chief scientific officer, analytical technologies. In this highly strategic position, Dr. Lindpaintner will look for opportunities to maximize the impact of the company’s leading portfolio of analytical technologies by assessing the evolving needs of the global life sciences industry.

“I’m pleased to welcome Klaus to our company,” said Marc N. Casper, president and chief executive officer of Thermo Fisher. “In these roles, Klaus will help us accelerate our long-term growth by looking for new opportunities to leverage our unique depth of capabilities in analytical technologies, ensuring a homogenous approach to our R&D efforts and raising Thermo Fisher’s profile as the innovation leader in our industry.”

Dr. Lindpaintner holds Bachelor of Science and Medical Doctorate degrees from the University of Innsbruck in Austria, and a Master of Public Health degree from Harvard University. He served as a Roche Distinguished Scientist and director of the Roche Center for Medical Genomics, as well as global head of molecular medicine policy and external affairs for F. Hoffman-La Roche AG. Most recently, Dr. Lindpaintner was the chief scientific officer and vice president of research and development at Strategic Diagnostics Inc.

His numerous academic appointments include positions at Jiao-Tong University in Shanghai, Stanford University, Harvard University and the University of London. He is also a Fellow of the American College of Physicians and a Fellow of the American College of Medical Genetics.

Dr. Liu, the seventh outside member of the company’s Scientific Advisory Board, is an international leader in cancer biology, genomics, human genetics and molecular biology. He is president and chief executive officer of The Jackson Laboratory, an internationally renowned research center dedicated to discovering the genetic basis for preventing, treating and curing human disease.

“Dr. Liu is a pioneer in cancer research, and his unique experience as both clinician and scientist will bring a valuable perspective to our Scientific Advisory Board,” Casper said. “We’re fortunate to have Dr. Liu as a member of this influential board, which plays an important role in guiding our innovation strategy.”

Dr. Liu also founded the Genome Institute of Singapore in 2001, building it into a major research institute of 27 laboratory groups. From 1996 to 2001, he was scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md. Dr. Liu earned his Bachelor of Science degree in chemistry and psychology, as well as his Medical Doctorate, at Stanford University. He served his internship and residency at Washington University's Barnes Hospital in St. Louis, followed by an oncology fellowship at Stanford.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ebola Sequencing Data Released to Global Research Community Online
To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.
Wednesday, June 03, 2015
Thermo's NGS Platform Selected for Nationwide Clinical Research Program
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.
Monday, June 01, 2015
Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Scientific Announces Listing of the Ion PGM Dx System
Company has completed the listing with the U.S. FDA as class II medical device.
Saturday, September 20, 2014
ATCC, CDC and Thermo Partner on Public Health RT-PCR Assay
New technology supports HIV-1 drug resistance surveillance in resource-limited countries.
Wednesday, June 25, 2014
Thermo Reports 22% Revenue Rise in Q1 2014
Results include the addition of Life Technologies as of February 4, 2014, and exclude the previously announced related divestitures as of March 22, 2014.
Wednesday, April 23, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Reports 6% Q4 Revenue Growth
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.
Friday, January 31, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Thermo Fisher Scientific Opens Its First Dry Powder Media Facility in APAC Region
Singapore facility delivers manufacturing redundancy and increases supply assurance for global biologic drug discovery and production.
Tuesday, August 06, 2013
Record Revenues for Thermo Fisher Scientific
Revenue for the quarter grew 6% to $3.26 billion in 2012, versus $3.09 billion in 2011.
Thursday, January 31, 2013
Thermo Fisher Scientific Announces Application Deadlines for Life Sciences Scholarships
Thermo Scientific Pierce Scholarship Winter/Spring semester applications due December 14, 2012.
Wednesday, November 14, 2012
Thermo Fisher Scientific Improves Cancer Diagnostics for West of Scotland Regional Cytogenetics Service
Thermo Scientific products improve automation and efficiency for cytogenetics department.
Tuesday, February 23, 2010
Thermo Fisher Scientific to Supply OPTEC LLC with Cancer Diagnostic Instrumentation as Part of National Oncological Program in Russia
Thermo Fisher Scientific, today announced a distribution partnership with OPTEC LLC, a provider of cutting-edge medical, surgical, microscopic and industrial metrology solutions in the territory of the Russian Federation and the CIS (Commonwealth of Independent States)
Wednesday, January 27, 2010
Thermo Fisher Scientific Names Recipients of RNAi Discovery Grants
More than $400,000 in RNAi screening tools awarded to advance biomedical research and drug discovery.
Friday, November 06, 2009
Scientific News
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
GMO Food Animals Should be Judged by Product, Not Process
In a world with a burgeoning demand for meat, milk and eggs, regulatory policies around the use of biotechnologies in agriculture need to be based on the safety and attributes of those foods rather than on the methods used to produce them, says a UC Davis animal scientist.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
Gene Drive Reversibility Introduces New Layer of Biosafety
Ability to introduce or reverse the spread of genetic traits through populations could one day improve pest management and disease control.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos